ArticleFrontiers in endocrinology2022

Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.

José Ignacio Martínez-Montoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.